Biodesix, Inc. - Common Stock (NQ:BDSX)

27.72 +0.39 (+1.43%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

Earnings Scheduled For May 11, 2021 ↗

May 11, 2021

Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 07, 2021

Before 10 a.m. ET on Wednesday, 49 companies set new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was China...

Via Benzinga

Looking Into Biodesix's Return On Capital Employed ↗

June 21, 2021

During Q1, Biodesix's (NASDAQ:BDSX) reported sales totaled $28.87 million. Despite a 110.44% in earnings, the company posted a loss of $5.58 million. In Q4, Biodesix brought in $...

Via Benzinga

Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer

June 17, 2021

From Biodesix, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

July 06, 2021

Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new...

Via Benzinga

Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test

June 15, 2021

From Biodesix, Inc.

Via Business Wire

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank

June 04, 2021

From Biodesix

Via Business Wire

Biodesix: Return On Capital Employed Insights ↗

June 03, 2021

During Q1, Biodesix's (NASDAQ:BDSX) reported sales totaled $28.87 million. Despite a 110.44% in earnings, the company posted a loss of $5.58 million. Biodesix collected $27.03...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 26, 2021

Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Biodesix to Present at the William Blair 41st Annual Growth Stock Conference

May 25, 2021

From Biodesix, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 21, 2021

Gainers Sio Gene Therapies (NASDAQ:SIOX) ...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 17, 2021

On Monday morning, 15 companies hit new 52-week lows. Noteworthy Highlights: Canadian Pacific Railway (NYSE:CP) was the largest firm by market cap to set a new 52-...

Via Benzinga

Biodesix, Inc. (BDSX) Q1 2021 Earnings Call Transcript ↗

May 11, 2021

BDSX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Biodesix Announces First Quarter 2021 Results

May 11, 2021

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time

April 28, 2021

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Plans

April 26, 2021

From Biodesix, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 26, 2021

Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of...

Via Benzinga

Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021

April 26, 2021

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management

April 22, 2021

From Biodesix, Inc.

Via Business Wire

Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients

April 10, 2021

From Biodesix, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.